Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.46B | 1.34B | 1.33B | 1.30B | 1.14B | 1.08B |
Gross Profit | 737.65M | 687.88M | 657.27M | 631.55M | 561.45M | 528.57M |
EBITDA | 277.32M | 280.84M | 261.61M | 227.44M | 196.94M | 166.54M |
Net Income | 194.84M | 197.22M | 174.86M | 149.98M | 129.66M | 112.37M |
Balance Sheet | ||||||
Total Assets | 1.70B | 1.52B | 1.39B | 1.37B | 1.38B | 1.14B |
Cash, Cash Equivalents and Short-Term Investments | 152.15M | 250.12M | 151.53M | 114.07M | 147.34M | 217.64M |
Total Debt | 161.62M | 129.66M | 80.66M | 129.15M | 84.01M | 47.29M |
Total Liabilities | 530.56M | 448.91M | 398.34M | 456.03M | 414.73M | 279.39M |
Stockholders Equity | 1.17B | 1.07B | 990.92M | 911.30M | 963.03M | 863.07M |
Cash Flow | ||||||
Free Cash Flow | 177.43M | 175.18M | 189.92M | 75.31M | 178.48M | 113.70M |
Operating Cash Flow | 206.85M | 255.07M | 209.15M | 118.45M | 205.66M | 140.98M |
Investing Cash Flow | -175.79M | -81.05M | -11.21M | -43.07M | -268.59M | -36.12M |
Financing Cash Flow | -33.62M | -70.53M | -163.57M | -102.09M | -12.32M | -163.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.07B | 24.54 | 27.48% | 1.86% | -1.05% | -2.78% | |
78 Outperform | $6.91B | 24.26 | 26.22% | 1.21% | 0.75% | 7.20% | |
77 Outperform | $3.58B | 60.92 | 2.58% | ― | 14.02% | -69.91% | |
76 Outperform | $3.30B | 17.23 | 17.80% | 1.38% | 8.62% | 3.59% | |
73 Outperform | $1.82B | ― | -21.34% | ― | 0.27% | -18.75% | |
72 Outperform | $7.09B | 14.49 | 16.26% | 2.60% | -5.44% | -16.05% | |
68 Neutral | £2.95B | 10.28 | 8.40% | 3.21% | 2.87% | -9.95% |
On May 16, 2025, Brady Corporation reported its fiscal 2025 third quarter financial results, highlighting a record adjusted earnings per share (EPS) and a tightening of its full-year EPS guidance. The quarter saw an 11.4% increase in sales, driven by acquisitions and organic growth, despite a slight decline due to foreign currency translation. Adjusted diluted EPS rose to a record $1.22, and the company returned $44.5 million to shareholders through dividends and share repurchases. Brady’s strategic focus on research and development and new product launches contributed to strong organic sales growth in the Americas and Asia, while the company remains vigilant amid global trade uncertainties.
The most recent analyst rating on (BRC) stock is a Buy with a $84.00 price target. To see the full list of analyst forecasts on Brady stock, see the BRC Stock Forecast page.